Tag: Cardiovascular Disease (CVD)
Researchers develop algorithm to predict impact of CPAP therapy on cardiovascular disease
April 13, 2026HME News Staff
NEW YORK – Researchers at Mount Sinai have created an analytic tool using machine learning that they say can predict cardiovascular disease risk in millions of patients with obstructive sleep apnea, according to findings recently published in Communications Medicine.
The researchers used a machine learning algorithm to create an analysis model that they say predicts how CPAP could affect an individual’s cardiovascular health – estimating each patient’s likeliness of benefit...
Study links untreated OSA with accelerated cardiovascular aging
December 17, 2025HME News Staff
COLUMBIA, Mo. - Researchers at the University of Missouri School of Medicine and the Marshall University Joan C. Edwards School of Medicine have found evidence that untreated obstructive sleep apnea (OSA) accelerates cardiovascular aging and significantly increases the risk of premature death.
Study design
Researchers, led by David Gozal, MD, MBA, PhD (Hon), vice president of health affairs at Marshall University and dean of the Joan C. Edwards...
NCPA launches pilot with Bristol Myers Squibb to address cardiovascular disease in rural communities
October 8, 2025HME News Staff
ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) has launched a partnership with Bristol Myers Squibb to address health-related social needs and care coordination for patients with cardiovascular disease (CVD). The two organizations are piloting specialized training for pharmacy technicians in community health. “We are pleased to partner with BMS to improve access to care for people in rural communities,” said B. Douglas Hoey, pharmacist, CEO of NCPA. “The...
Researchers use grant to ID risk for cardiovascular disease in OSA patients
March 12, 2024HME News Staff
NEW YORK – Mount Sinai researchers have received a $3 million grant from the National Institutes of Health to develop and study AI-powered models to identify the risk of cardiovascular disease events in patients with obstructive sleep apnea. Researchers will use machine-learning techniques on comprehensive multi-modal datasets to identify patients at enhanced risk for buildup of fats and cholesterol in the artery walls, and heightened risk for cardiovascular events such as heart attack and...
One Drop targets cardiovascular disease
November 19, 2021Theresa Flaherty, Managing Editor
NEW YORK – While One Drop has made a name for itself in the diabetes management space, the provider of digital health solutions understands there’s a lot of existing overlap between diabetes and a host of other chronic conditions.
It recently launched, in partnership with Bayer, a cardiovascular prevention module to help users reduce cardiovascular disease risk. The user-friendly mobile app offers a platform for consumers looking for ways to engage with their...
One Drop launches cardiovascular prevention tool
October 27, 2021HME News Staff
NEW YORK – One Drop has released a digital, AI-enabled cardiovascular disease prevention module, the first in its expansion into a wider range of therapeutic areas beyond diabetes management.
The module, developed in partnership with Bayer Pharmaceuticals, provides members with a personalized digital health program that combines clinical best practices with the latest in technology and predictive analytics to reduce cardiovascular disease risk.
"The new CVD prevention module...
AHA releases statement on OSA and cardiovascular disease
June 29, 2021HME News Staff
YARMOUTH, Maine – Obstructive sleep apnea is often under recognized and understated in cardiovascular practice, despite its high prevalence in patients with heart diseases and the vulnerability of cardiac patients to OSA-related stressors and adverse cardiovascular outcomes, according to a new scientific statement from the American Heart Association. “We recommend screening for OSA in patients with resistant/poorly controlled hypertension, pulmonary hypertension, and recurrent atrial...
Sleep apnea impairs blood pressure regulation
November 18, 2016HME News Staff
KELOWNA, British Columbia - Sleep apnea has an immediate negative impact on blood pressure, according to a new study. Just six hours of fluctuating oxygen levels associated with sleep apnea impairs the body's ability to regulate blood pressure, say researchers at the University of British Columbia's Okanagan campus. The study, in which healthy young adults wore ventilating masks for six hours and had their oxygen levels alternated to mimic apnea symptoms, also found damaging blood flow patterns in...
Study casts doubt on impact of CPAP therapy on cardiovascular events
August 30, 2016HME News Staff
WALTHAM, Mass. - CPAP therapy plus usual care, versus usual care alone, does not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease, according to a study published Aug. 28 on the website of the New England Journal of Medicine.
“This study was not powered to provide definitive answers regarding the effects of CPAP on secondary cardiovascular end points, but there was no indication of a significant benefit with respect...
Report: Remote cardiac monitoring to expand by 2016
March 4, 2013HME News Staff
LONDON - The U.S. market for remote cardiac monitoring devices is projected to increase by 25% from 2011 to 2016, according to a report from IHS, a market research firm. The report, titled “World Market for Diagnostic Cardiology Devices and Remote Cardiac Monitoring Services,” attributes the increase to a greater emphasis among healthcare providers to cut expenses by gathering data on patients outside hospitals. In the U.S., by far the world's leading region for remote cardiac monitoring,...